Daré Bioscience, Inc. (DARE)
0.7518
-0.06
(-6.89%)
USD |
NASDAQ |
Sep 24, 16:00
0.7518
0.00 (0.00%)
After-Hours: 19:59
Daré Bioscience Total Return Level : 0.8074 for Sept. 23, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 23, 2026 | 0.8074 |
| September 22, 2026 | 0.85 |
| September 21, 2026 | 0.81 |
| September 18, 2026 | 0.7843 |
| September 17, 2026 | 0.7478 |
| September 16, 2026 | 0.7255 |
| September 15, 2026 | 0.7301 |
| September 14, 2026 | 0.7363 |
| September 11, 2026 | 0.706 |
| September 10, 2026 | 0.7051 |
| September 09, 2026 | 0.7166 |
| September 08, 2026 | 0.713 |
| September 04, 2026 | 0.721 |
| September 03, 2026 | 0.7131 |
| September 02, 2026 | 0.74 |
| September 01, 2026 | 0.7702 |
| August 31, 2026 | 0.761 |
| August 28, 2026 | 0.735 |
| August 27, 2026 | 0.7387 |
| August 26, 2026 | 0.7506 |
| August 25, 2026 | 0.8207 |
| August 24, 2026 | 0.8015 |
| August 21, 2026 | 0.8199 |
| August 20, 2026 | 0.8092 |
| August 19, 2026 | 0.8244 |
| Date | Value |
|---|---|
| August 18, 2026 | 0.7682 |
| August 17, 2026 | 0.8102 |
| August 14, 2026 | 0.93 |
| August 13, 2026 | 1.37 |
| August 12, 2026 | 1.44 |
| August 11, 2026 | 1.44 |
| August 10, 2026 | 1.36 |
| August 07, 2026 | 1.40 |
| August 06, 2026 | 1.33 |
| August 05, 2026 | 1.34 |
| August 04, 2026 | 1.34 |
| August 03, 2026 | 1.28 |
| July 31, 2026 | 1.22 |
| July 30, 2026 | 1.24 |
| July 29, 2026 | 1.16 |
| July 28, 2026 | 1.185 |
| July 27, 2026 | 1.32 |
| July 24, 2026 | 1.28 |
| July 23, 2026 | 1.26 |
| July 22, 2026 | 1.22 |
| July 21, 2026 | 1.25 |
| July 20, 2026 | 1.34 |
| July 17, 2026 | 1.96 |
| July 16, 2026 | 1.94 |
| July 15, 2026 | 2.07 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Nektar Therapeutics | 57.66 |
| Elite Pharmaceuticals, Inc. | 0.2489 |
| Eton Pharmaceuticals, Inc. | 55.61 |
| ANI Pharmaceuticals, Inc. | 74.43 |
| Corcept Therapeutics, Inc. | 112.94 |